No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa
UAE – AstraZeneca has officially launched its new sustainable offices at the TECOM Group’s Dubai Science Park as part of the biopharmaceutical company’s flagship sustainability strategy, Ambition Zero Carbon. Spanning…
Read More
AFRICA — Futurize, in partnership with pharmaceutical giant AstraZeneca and co-funded by Bristol Myers Squibb, has officially introduced “FuturizeU,” a groundbreaking HealthTech incubator program set to run from September 12…
Read More
UNITED KINGDOM — AstraZeneca’s subsidiary, Alexion, has partnered with Verge Genomics, tapping into the power of artificial intelligence (AI) to revolutionize drug discovery for rare neurodegenerative and neuromuscular diseases. The…
Read More
USA —In a dramatic legal move, pharmaceutical giant AstraZeneca has thrown down the gauntlet against the Biden administration’s attempt to rein in drug prices. The company contends that the measures,…
Read More
SWEDEN — AstraZeneca, a trailblazer in championing sustainability within the pharmaceutical realm, is intensifying its dedication to clean energy initiatives, particularly in Sweden. The British pharmaceutical giant is forging an…
Read More
USA— The U.S. Centers for Disease Control and Prevention (CDC) advisory panel has announced its endorsement of the utilization of Sanofi in collaboration with AstraZeneca’s antibody therapy of Beyfortus (nirsevimab)…
Read More
UNITED KINGDOM – AstraZeneca has tapped Sharon Barr as the new Executive Vice President of Biopharmaceuticals Research and Development (R&D) at the Anglo-Swedish pharmaceutical company. Sharon Barr has replaced Mene…
Read More
KENYA— Global pharmaceutical giant, AstraZeneca, in partnership with the Ministry of Health (MoH) Kenya & the Aga Khan University Hospital East Africa has launched an innovative treatment therapy for the…
Read More
INDIA – AstraZeneca Pharma India Ltd. (AstraZeneca India), a science-led biopharmaceutical company, has achieved a major milestone with its drug, Dapagliflozin, indicated for adult patients with heart failure (HF). The…
Read More
USA — US FDA has granted approval to Sanofi and AstraZeneca’s Beyfortus (nirsevimab) as a preventive treatment for respiratory syncytial virus (RSV) lower respiratory tract disease in newborns and infants.…
Read More